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Summary A study of mortality from hepatoma and hepatic cirrhosis was conducted in Taiwan, where their
mortality rates are among the highest in the world in 1980 being 26.10 and 8.14 per 100,000 population for
males and females, respectively, for hepatoma, and 33.01 and 12.90 for males and females, respectively, for
cirrhosis. The secular trends of hepatoma and hepatic cirrhosis death rates have been increasing, especially in
males, with consequent increase in the sex ratio. The large difference in mortality rates between males and
females and the increasing trends in the sex ratio suggest that other factors besides hepatitis B virus (HBV),
are involved in the aetiology of hepatoma and cirrhosis of liver.
Because the areas with the highest incidence and
death rates from hepatoma are also known to be
endemic or hyperendemic for HBV infection, a
causal relationship between HBV with this cancer
was suspected some time ago (Steiner, 1960).
Furthermore, liver cancer usually occurs with
concurrent macronodular cirrhosis so that it is also
thought that these two diseases at least partly share
a common aetiology. In Taiwan, recently, cancer
has ranked first among the ten leading causes of
death and hepatoma has been the most common
malignancy accounting for 26.10 and 8.14 deaths
per 100,000 for males and females, respectively, in
1980. Furthermore, cirrhosis of the liver ranked the
seventh of the ten leading causes of death in 1980
and was, in fact, more common than hepatoma
accounting for 33.01 and 12.90 deaths per 100,000,
respectively, for males and females. The prevalence
of HBV infection is very high in Taiwan and it is
reported that more than ninety percent of the
adults have been infected and among them more
than fifteen percent are carriers of HBV surface
antigen (HBsAg) (Chen et al., 1978; Wu et al.,
1980). The present communication concerns the
mortality of hepatoma and hepatic cirrhosis in
Taiwan, together with the putative causal
association of HBV with hepatoma and cirrhosis of
the liver.
Materials and methods
The term hepatoma used in this study refers to
malignant neoplasms of the liver, and was used
because the materials were based on death certifi-
cates and most of them were not confirmed
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histologically. Hepatoma and cirrhosis of liver were
classified according to International Classification of
Diseases, Injuries and Causes of Death (ICD), 8th
Revision (WHO, 1965). Because Taiwan started to
use the 8th Revision of ICD from 1971, all of the
death certificates from 1957 to 1970 were reviewed
by one of us (Lin) and liver cancer was classified
in the same fashion as the 8th Revision of the ICD.
From 1971 to 1980 the data on causes ofdeath were
obtained from official annual Chinese government
publications on vital statistics. (Taiwan provincial
Government, 1971-73; Republic of China, 1974-80).
For the international comparison, the materials were
obtained from the Vital Statistics and Causes of
Death published by WHO (1971-80). The standard
population used by WHO was applied for the
calculation of age-adjusted rates. Linear regression
was used for the analysis of secular trends both
of the mortality rates and of the sex ratio (Male
rate/Female rate x 100) of mortality.
Results
Secular trends
The secular trends of age-adjusted death rates of
hepatoma and cirrhosis of the liver are illustrated in
Figures 1 and 2, respectively. Both show upward
trends for the two sexes combined from 1957
through 1967 which then levels off in the
subsequent years. When one analyzed the sexes
separately, however, an upward trend for the entire
period 1957 to 1980 was noted for males
(Y=17.86+0.39X, tb=7.41, P<0.001) but not for
females (Y=8.27+0.037X, tb= 1.31, P>0.10) for
hepatoma. For cirrhosis of the liver the upward
trends were noted for the entire period 1957 to
1980 for the two sexes but was much more
remarkable for males than for females (Males,
Y=21.47+0.63X, tb= 10.86, P<0.001; Females,
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Figure 1 Secular trends of the age-adjusted death
rates to WHO standard population of hepatoma by
sex. ---Male ......... Female - Total.
Y= 11.67+0.079X, tb=2.56, P<0.025). The
changes in the sex ratios of the death rates for
hepatoma and cirrhosis of the liver by year are
shown in Figure 3. Upward trends were observed
for both hepatoma and cirrhosis of the liver
(Hepatoma, Y=215.25+3.58X, tb=8.32, P<0.001;
Cirrhosis of the liver, Y=185.74+3.65X, tb=7.43,
P<0.001).
Age-specific death rates
Table I shows the age-specific death rates for
hepatoma and cirrhosis of the liver by sex,
respectively, for 1971-80. J-shape curves occur
when these data are plotted on a log linear figure
for both diseases except for a little decline in the
older age groups for hepatoma.
Death rates by area
Figures 4 and 5 show maps of the age-adjusted
death rates for hepatoma and cirrhosis of the liver,
respectively, by township for 1971-80 in Taiwan.
For hepatoma while significantly higher rates were
observed for eastern mountainous areas of Taiwan,
significantly lower rates were recorded for western
1957 60 65 70 75 1980
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Figure 2 Secular trends of the age-adjusted death
rates to WHO standard population of cirrhosis of liver
by sex. ----Male .........Female . Total.
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Figure 3 Secular trends to the sex ratios of the age-
adjusted death rates for hepatoma and cirrhosis of
liver. - Hepatoma Cirrhosis of liver.
mountainous areas. It is noteworthy that higher
rates were recorded in some of the coastal areas in
the western part of Taiwan, especially those areas
where blackfoot disease has been prevalent (Wu et
al., 1981). For cirrhosis of the liver, significantly
higher death rates were noted for most of the
eastern part of Taiwan and in some western coastal
areas.
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International comparison
The age-adjusted death rates for hepatoma and
cirrhosis of the liver of selected countries are shown
in Tables II and III respectively. Apparently the
death rates for both hepatoma and cirrhosis of the
liver in Taiwan belong at, or near the top among
those countries for both males and females.
Table II Age-adjusted death rates from hepatoma in 11
selected countries by sex (1979-1981)
Country Male Female
Taiwan 26.10 8.14
Japan 10.77 3.12
Austria 3.28 1.53
Singapore 2.74 1.43
Israel 2.44 0.72
France 2.33 0.68
Chile 2.30 1.46
Germany (Fed. Rep. of) 1.56 0.63
USA 1.23 0.41
UK 1.22 0.34
Netherlands 1.09 0.32
Rates are numbers of deaths per 100,000 population
and adjusted to the WHO standard population.
Table III Age-adjusted death rates of cirrhosis of liver in
20 selected countries by sex (1978-1980)
Country Male Female
Chile 60.78 22.23
Italy 33.42 10.36
Taiwan 33.01 12.90
France 32.28 12.72
Austria 31.17 8.65
Germany 25.73 8.75
Mauritius 23.41 3.44
Egypt 17.29 7.07
Japan 16.01 4.42
USA 15.99 7.34
Canada 15.15 6.32
Switzerland 12.98 3.54
Denmark 11.66 4.08
Sweden 10.74 4.54
Thailand 10.13 3.27
Israel 9.95 3.62
Philippines 9.32 3.22
Singapore 8.98 3.28
Netherlands 5.37 2.06
UK 2.99 2.17
Rates are numbers of deaths per 100,000 population
and adjusted to the WHO standard population.
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Figure 4 Map of the age-adjusted death rates of hepatoma in Taiwan by areas (1971-1980). * Significantly
higher than Taiwan area. 19.7-30.4/100,000. 0 Not significant. 18.0-19.6/100,000. Cl Significantly lower than
Taiwan area. 11.4-16.6/100,000.MORTALITY OF HEPATOMA AND CIRRHOSIS OF LIVER 973
Figure 5 Map of the age-adjusted death rates of cirrhosis of liver in Taiwan by area (1971-1980). H
Significantly higher than Taiwan area. 26.1-36.2/100,000. E Not significant. 24.1-25.3/100,000. El
Significantly lower than Taiwan area. 18.3-21.9/100,000.974 T.M. LIN et al.
Discussion
In reviewing the international mortality of
hepatoma and cirrhosis of liver, it is evident that
the death rates of these two liver diseases in Taiwan
are among the highest in the world. Because of the
high case-fatality rate and short duration of the
disease process, especially for hepatoma, the death
rates may also represent the incidence rates. An
interesting observation in this study is that while
the secular trend of the death rates of hepatoma
has been increasing for males, virtually no change
of the rates for females is noted over the time
period. For cirrhosis of the liver, though increases
in the death rates are observed for both sexes, the
upward trend is more remarkable for males.
Accordingly the secular trends of sex ratios of
mortality from hepatoma and cirrhosis of liver have
been increasing. The increasing death rates may be
partly due to the improvement of diagnosis.
However, the more rapid increase for males than
for females cannot be explained only by the
improvement of diagnosis. Saracci and Repetto
(1980) reported that among 30 selected cancer
registries covering 37 populations in 18 countries
the trends in incidence of primary liver cancer
(PLC) are similar in males and females. However,
the sex ratios of PLC in most of these areas show
definite male preponderance. The large difference of
mortality rates of hepatoma and cirrhosis of liver
between males and females and the increasing
trends of sex ratios of mortality of these two
diseases suggest that factors in addition to HBV are
important in the aetiology of these diseases because
similar rates of HBV infection and carrier status
have been reported in Taiwan for the two sexes and
more than 80% of hepatomas and cirrhosis of the
liver in Taiwan have been found to be permanent
carriers of HBV (Chen et al., 1978; Wu et al.,
1980).
Several reasons can be considered for the
increasing trends of sex ratios in mortality from
hepatoma and cirrhosis of liver in Taiwan, among
which the reliability of the data seems most critical.
Though the registration of death is virtually
universal in Taiwan, the exactness of the diagnosis
of causes of death is, of course, as in all countries
subject to some uncertainty. Recent studies
conducted by the National Health Administration
in Taiwan (1979-80) found that although there are
very few autopsies performed, about 40% of
hepatomas were histologically confirmed by biopsy,
which compares favourably with histological
confirmation rates for this neoplasm in various
cancer registries throughout the world.
Furthermore, most cases of hepatoma also have
cirrhosis so that there is substantial room for
misdiagnosis as well as overlap between these two
disease entities. The difficulty of diagnosing
hepatoma and cirrhosis of liver makes the reliability
of the data uncertain to an unknown extent
especially since these are based on death
certificates. However, it should be noted that most
cirrhosis in Taiwan is macronodular which is most
frequently due to HBV infection rather than
micronodular variety which is more associated with
excess alcohol consumption. Finally it may be
noted that though the present study combined
cancer of the liver and cancer of the intrahepatic
bile duct (ICD 155), more than 95% of the cases in
Taiwan are of cancer of the liver.
The large difference in mortality rates for
hepatoma and cirrhosis of the liver between males
and females as well as the increasing trends of the
sex ratios in Taiwan, however, may suggest that
besides HBV antigenemia, other factors may be
involved in the aetiology of these diseases. The
reasons why HBsAg disappears in most patients
with HBV hepatitis while a minority of patients
become persistent carriers of HBsAg have not been
elucidated, but may relate to either viral or host
factors. The bulk of evidence, however, suggests
that host factors are more important in the
development of the chronic carrier state. Blumberg
et al. (1969) first reported an autosomal recessive
inheritance of susceptibility to infection of HBV
and suggested that genetic factors are involved in
those who become carriers, though subsequent data
from several studies are inconsistent with such
inheritance. (Vyas, 1974; Szmuness et al., 1975;
Stevens & Beasley, 1976). Holland & Alter (1976)
also suggested that host factors are more important
in the development of the chronic carrier state than
viral factors. Renal dialysis patients, when infected,
tend to develop mild clinical disease and a
persistent carrier state, whereas the staff pre-
sumably infected with the same virus, develop
acute, often severe disease, but no predisposition to
have chronic antigenemia. Moreover, the obser-
vation of high levels of HBsAg in asymptomatic
persons otherwise free of liver diseases also favours
a host factor. In addition to those with renal
disease, patients with leukaemia, Down's syndrome
and lepromatous leprosy also have exhibited a
striking tendency to develop chronic HBsAg carrier
status. (Blumberg et al., 1967).
The association of HBV with hepatoma and
cirrhosis of liver has been documented by many
workers (Steiner, et al., 1960; Szmuness et al., 1978;
Tabor et al., 1977; Summer et al., 1978; Beasley et
al., 1981). The following facts have been included: a
high prevalence of HBsAg in hepatoma and
patients with cirrhosis of liver, a high incidence of
hepatoma and cirrhosis of liver among HBsAg
carriers, and the detection of HBV genomes in
hepatoma cells and animal models. However, otherMORTALITY OF HEPATOMA AND CIRRHOSIS OF LIVER 975
environmental factors may be involved in the
aetiology of hepatoma and cirrhosis of liver.
Aflatoxin may act synergistically or even indepen-
dently of HBV in the causation of hepatoma. In
Taiwan the contamination of foodstuff with
aflatoxins is a serious problem (Tung et il., 1967;
Ling ct al., 1967; Ling et al., 1968). It is considered
that the high incidence of PLC in Taiwan may be
explained partly by aflatoxin (Tung et al., 1967).
Van Rensburg et al. (1985) suggested that an
interaction between HBV and aflatoxin may be
responsible for the exceptionally high rates of
hepatocellular carcinoma (HCC) evident in parts of
Africa and Asia and indicated that aflatoxin has a
late stage effect on the development of HCC.
Alcohol is considered to be one of the aetiological
factors for hepatoma in some countries and the
major one for cirrhosis in many parts of the world.
Alcohol consumption and chronic alcoholism are
known to be much less common in Chinese than
other ethnic groups and constitute a minor social
and medical problem in Taiwan. It is especially
noteworthy that there is very little alcohol
consumption among Chinese women. In a case-
control study conducted recently by the authors,
neither alcohol consumption nor duration and/or
drinking frequency were found to be significantly
associated with hepatoma. (Lin et al., to be
published). Malnutrition, malaria and intestinal
parasites may be co-factors in some countries but in
Taiwan both malnutrition and malaria have been
almost nonexistent for more than 25 years. It is
suggested that the possible role of factors
additional to HBV should be investigated to clarify
the remarkable sex difference and the increasing
trends of sex ratios in mortality rates of hepatoma
and cirrhosis of liver in Taiwan.
The authors are grateful to Dr R.P. Beasley, University of
Washington Medical Research Unit, and Dr R.S. Lin,
National Taiwan University College of Medicine for their
suggestions and reading this manuscript. Thanks are due
to Mr T.S. Tsai for technical assistance.
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